Informações:
Falhas:
ID
34669
Descrição
An 8-week Study to Evaluate the Dose Response of AHU377 in Combination With Valsartan 320 mg in Patients With Mild-to-moderate Systolic Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01281306
Link
https://clinicaltrials.gov/show/NCT01281306
Palavras-chave
Versões (1)
- 22/01/2019 22/01/2019 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
22 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Systolic Hypertension NCT01281306
Eligibility Systolic Hypertension NCT01281306
- StudyEvent: Eligibility
Similar models
Eligibility Systolic Hypertension NCT01281306
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Informed Consent | Systolic hypertension, mild | Systolic hypertension Moderate | Did not receive therapy or drug for | Antihypertensive therapy
Item
written informed consent must be obtained before any assessment is performed. patients with mild-to-moderate systolic hypertension, untreated or currently taking antihypertensive therapy.
boolean
C0021430 (UMLS CUI [1])
C1845210 (UMLS CUI [2])
C0221155 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C0332155 (UMLS CUI [4])
C0585941 (UMLS CUI [5])
C1845210 (UMLS CUI [2])
C0221155 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C0332155 (UMLS CUI [4])
C0585941 (UMLS CUI [5])
Able to communicate | Protocol Compliance | Medication Compliance Good
Item
ability to communicate and comply with all study requirements and demonstrate good medication compliance (≥ 80% compliance rate) during the run-in period.
boolean
C2364293 (UMLS CUI [1])
C0525058 (UMLS CUI [2])
C3489773 (UMLS CUI [3,1])
C0205170 (UMLS CUI [3,2])
C0525058 (UMLS CUI [2])
C3489773 (UMLS CUI [3,1])
C0205170 (UMLS CUI [3,2])
Hypertension, severe
Item
severe hypertension
boolean
C4013784 (UMLS CUI [1])
Angioedema Drug-induced | Angioedema
Item
history of angioedema, drug-related or otherwise, as reported by the patient.
boolean
C0002994 (UMLS CUI [1,1])
C0458082 (UMLS CUI [1,2])
C0002994 (UMLS CUI [2])
C0458082 (UMLS CUI [1,2])
C0002994 (UMLS CUI [2])
Pregnancy | Breast Feeding
Item
pregnant or nursing (lactating) women.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Childbearing Potential | Exception Use of Contraceptive methods
Item
women of child-bearing potential (wocbp), unless they are using adequate birth control methods.
boolean
C3831118 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
C1705847 (UMLS CUI [2,1])
C1524063 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
Secondary hypertension
Item
history or evidence of a secondary form of hypertension.
boolean
C0155616 (UMLS CUI [1])
Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,2])